Crossmark

The post-translational modification of NuMA in cancer cells is a new target for cancer eradication

Crossref DOI link: https://doi.org/10.1038/s41419-025-07868-7

Published Online: 2025-07-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cohen-Armon, Malka https://orcid.org/0000-0003-1021-7564
License Information

Text and Data Mining valid from 2025-07-18

Version of Record valid from 2025-07-18
More Information

Article History

Received: 6 January 2025

Revised: 31 May 2025

Accepted: 7 July 2025

First Online: 18 July 2025

Competing interests

: The author declares no competing interests.